X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4954) 4954
Publication (284) 284
Conference Proceeding (17) 17
Book Chapter (16) 16
Dissertation (10) 10
Book Review (9) 9
Government Document (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3433) 3433
male (2622) 2622
rats (2571) 2571
8-hydroxy-2-tetralin - pharmacology (2176) 2176
serotonin receptor agonists - pharmacology (1445) 1445
neurosciences (1374) 1374
pharmacology & pharmacy (1330) 1330
8-hydroxy-2-tetralin (1227) 1227
serotonin (1151) 1151
receptors, serotonin - drug effects (1026) 1026
serotonin antagonists - pharmacology (936) 936
piperazines - pharmacology (873) 873
rats, sprague-dawley (844) 844
5-ht (809) 809
8-oh-dpat (799) 799
tetralin (787) 787
dose-response relationship, drug (770) 770
tetrahydronaphthalenes - pharmacology (668) 668
rats, wistar (665) 665
receptors, serotonin - metabolism (653) 653
female (581) 581
mice (558) 558
serotonin - metabolism (550) 550
receptors, serotonin - physiology (547) 547
rat (527) 527
receptors, serotonin, 5-ht1 (527) 527
rats, inbred strains (493) 493
index medicus (484) 484
receptors (463) 463
behavior, animal - drug effects (444) 444
brain (442) 442
pyridines - pharmacology (438) 438
serotonin - pharmacology (426) 426
5-ht1a receptor (381) 381
receptor (366) 366
motor activity - drug effects (363) 363
psychiatry (339) 339
5-hydroxytryptamine (334) 334
in vitro techniques (322) 322
hippocampus - metabolism (315) 315
hippocampus - drug effects (314) 314
humans (307) 307
serotonin - physiology (307) 307
5-ht1a receptors (306) 306
receptor, serotonin, 5-ht1a - metabolism (293) 293
brain - metabolism (289) 289
rat-brain (286) 286
neurons - drug effects (285) 285
neurons (272) 272
hippocampus (265) 265
engineering, chemical (252) 252
8-hydroxy-2-tetralin - metabolism (251) 251
raphe nuclei - drug effects (241) 241
time factors (240) 240
brain - drug effects (239) 239
behavioral sciences (236) 236
8-hydroxy-2-tetralin - administration & dosage (233) 233
analysis of variance (233) 233
buspirone (233) 233
chemistry, physical (219) 219
agonists (218) 218
drug interactions (213) 213
microdialysis (209) 209
kinetics (207) 207
autoradiography (202) 202
buspirone - pharmacology (197) 197
dopamine (196) 196
serotonin uptake inhibitors - pharmacology (195) 195
naphthalenes - pharmacology (194) 194
serotonin receptors (193) 193
amphetamines - pharmacology (188) 188
biochemistry & molecular biology (186) 186
hydrogenation (185) 185
hydrocarbons (183) 183
anxiety (181) 181
indoles - pharmacology (179) 179
neurons - physiology (178) 178
binding-sites (176) 176
dorsal raphe nucleus (176) 176
8-oh-dpattetralin (175) 175
body temperature - drug effects (175) 175
binding (173) 173
disease models, animal (173) 173
energy & fuels (173) 173
pyrimidines - pharmacology (173) 173
radioligand assay (170) 170
5-ht1a (169) 169
tetrahydronaphthalenes - metabolism (165) 165
receptor, serotonin, 5-ht1a - physiology (161) 161
antagonist (157) 157
serotonin 5-ht1 receptor agonists (155) 155
catalysts (154) 154
depression (153) 153
behavior (151) 151
inhibition (151) 151
agonist (149) 149
physiology (146) 146
serotonin receptor agonists - administration & dosage (146) 146
electrophysiology (145) 145
brain chemistry - drug effects (143) 143
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4926) 4926
Japanese (50) 50
Russian (28) 28
Chinese (16) 16
German (8) 8
French (2) 2
Korean (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2012, Volume 7, Issue 8, p. e44652
The drug 4-methylmethcathinone (4-MMC; aka, mephedrone, MMCAT, "plant food'', "bath salts'') is a recent addition to the list of popular recreational... 
METHAMPHETAMINE | ECSTASY | CORE BODY-TEMPERATURE | MULTIDISCIPLINARY SCIENCES | 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA | CATHINONE | DOPAMINE | MEPHEDRONE | SEROTONIN | AMPHETAMINE | NUCLEUS-ACCUMBENS | Temperature | Central Nervous System Stimulants - pharmacology | Rats, Wistar | Propiophenones - pharmacology | Male | Nucleus Accumbens - physiology | Propiophenones - blood | Time Factors | Injections, Subcutaneous | Propiophenones - administration & dosage | Body Temperature Regulation - drug effects | Methamphetamine - analogs & derivatives | Dopamine - metabolism | Locomotion - drug effects | Methamphetamine - pharmacology | Rats | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Rats, Sprague-Dawley | Propiophenones - pharmacokinetics | 8-Hydroxy-2-(di-n-propylamino)tetralin - administration & dosage | Animals | Microdialysis | Methamphetamine - administration & dosage | Methamphetamine - pharmacokinetics | Serotonin - metabolism | Nucleus Accumbens - drug effects | Central Nervous System Stimulants - administration & dosage | Methamphetamine - blood | Complications and side effects | Dosage and administration | Resveratrol | Ecstasy (Drug) | Ecstasy | Salts | Food plants | Neurosciences | Similarity | Neurobiology | MDMA | Methamphetamines | Ambient temperature | Temperature effects | Rodents | Drug dosages | Locomotor activity | Pharmaceutical sciences | Dopamine | Serotonin | Body temperature | Methamphetamine | Nucleus accumbens | Studies | 8-Hydroxy-2-(di-n-propylamino)tetralin | Psychopharmacology | Hyperthermia | Hypothermia
Journal Article
Journal Article
Journal of Catalysis, ISSN 0021-9517, 04/2008, Volume 255, Issue 2, pp. 220 - 227
Two metal-organic frameworks, [Cu(2-pymo) ] and [Co(PhIM) ] (2-pymo = 2-hydroxypyrimidinolate; PhIM = phenylimidazolate), containing respectively Cu and Co... 
Coordination polymer | Tetralin aerobic oxidation | Metal-organic framework | AUTOXIDATION | COPPER(II) | STABILITY | POLY(4-VINYLPYRIDINE) | CHEMISTRY, PHYSICAL | HETEROGENEOUS CATALYSIS | tetralin aerobic oxidation | coordination polymer | metal-organic framework | ENGINEERING, CHEMICAL | PYRIDINE COMPLEXES | COORDINATION POLYMERS | SELECTIVITY | DERIVATIVES | COBALT
Journal Article
Catalysis Today, ISSN 0920-5861, 2018
Ti-CMK-3 carbon mesoporous was prepared using a novel synthesis method. This new method avoids the hard template synthesis used commonly. The method developed... 
N-compounds | Short time | Tetralin | HDT | Direct synthesis | Ti
Journal Article
Neuron, ISSN 0896-6273, 04/2012, Volume 74, Issue 2, pp. 277 - 284
mTOR is a regulator of cell growth and survival, protein synthesis-dependent synaptic plasticity, and autophagic degradation of cellular components. When... 
LOCALIZATION | AMPA RECEPTORS | DOPAMINE RELEASE | NEURONS | NEURODEGENERATION | AXONAL-TRANSPORT | MICE | AUTOPHAGY | UP-REGULATION | NEUROSCIENCES | DEGENERATION | Dopamine Plasma Membrane Transport Proteins - metabolism | Tyrosine 3-Monooxygenase - metabolism | Microtubule-Associated Proteins - genetics | TOR Serine-Threonine Kinases - metabolism | Microtubule-Associated Proteins - metabolism | Male | Presynaptic Terminals - ultrastructure | Autophagy - drug effects | Brain - metabolism | TOR Serine-Threonine Kinases - antagonists & inhibitors | Behavior, Animal - drug effects | Autophagy - genetics | Immunosuppressive Agents - pharmacology | Dopamine - metabolism | Microscopy, Electron, Transmission | Brain - cytology | Gene Expression Regulation - genetics | 8-Hydroxy-2-(di-n-propylamino)tetralin - analogs & derivatives | RNA, Messenger - genetics | Genotype | Mice, Transgenic | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Dopamine Plasma Membrane Transport Proteins - genetics | Sirolimus - pharmacology | Gene Expression Regulation - drug effects | Autophagy-Related Protein 7 | Animals | Analysis of Variance | Corpus Striatum - drug effects | Electrochemistry | Presynaptic Terminals - metabolism | Mice | In Vitro Techniques | Proteins | Neurosciences | Universities and colleges | Neurons | Dopamine | Protein synthesis | Rodents | Parkinsons disease | Behavior | Autophagy
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 07/2015, Volume 463, Issue 3, pp. 180 - 186
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 07/2011, Volume 100, Issue 7, pp. 2996 - 3009
The pharmacokinetic (PK) and pharmacodynamic (PD) properties of the active (S)-enantiomer of the potent dopamine (DA) agonist... 
diffusion | blood–brain barrier | microdialysis | active transport | transdermal drug delivery | controlled delivery | mathematical model | individualized drug therapy | pharmacokinetic/pharmacodynamic models | iontophoresis | blood-brain barrier | RAT STRIATUM | RELEASE | TRANSPORT | INVIVO | MODELS | IN-VIVO | ANESTHETICS | DOPAMINE METABOLISM | PARKINSONS-DISEASE | pharmacokinetic/pharmacodynamic models; iontophoresis | Active transport | Controlled delivery | Microdialysis | Blood-brain barrier | Individualized drug therapy | Transdermal drug delivery | Diffusion | Mathematical model | Pharmacokinetic/pharmacodynamic models; iontophoresis | CHEMISTRY, MEDICINAL | CHEMISTRY, MULTIDISCIPLINARY | PHARMACOLOGY & PHARMACY | Isoflurane - pharmacology | Rats, Wistar | Male | Administration, Cutaneous | 8-Hydroxy-2-(di-n-propylamino)tetralin - blood | Iontophoresis | Basal Ganglia - secretion | Dopamine - secretion | Antiparkinson Agents - chemistry | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacokinetics | Dopamine Agonists - blood | Anesthetics, Inhalation - pharmacology | 8-Hydroxy-2-(di-n-propylamino)tetralin - analogs & derivatives | Dopamine Agonists - pharmacokinetics | Rats | Antiparkinson Agents - pharmacokinetics | 8-Hydroxy-2-(di-n-propylamino)tetralin - administration & dosage | Animals | Antiparkinson Agents - blood | Models, Biological | Dopamine Agonists - administration & dosage | Antiparkinson Agents - administration & dosage | Infusions, Intravenous | Nonlinear Dynamics | Delayed-Action Preparations | 8-Hydroxy-2-(di-n-propylamino)tetralin - chemistry | Dopamine Agonists - chemistry | Basal Ganglia - drug effects
Journal Article
Applied Catalysis A, General, ISSN 0926-860X, 10/2017, Volume 547, pp. 12 - 21
[Display omitted] •Design of hydrocracking catalysts for Polyaromatics conversion into BTX is studied.•Metallic functions in the hydrocracking catalysts should... 
H-ZSM-5 | H-Beta | Polycyclic aromatic hydrocarbons | Tetralin hydrocracking | Hybrid zeolite | BTX | Sulfide metals | COUPLED HYDROGENATION | LIGHT-CYCLE OIL | CONVERSION | DECALIN | HYDRODESULFURIZATION | CHEMISTRY, PHYSICAL | ENVIRONMENTAL SCIENCES | GAS-OIL | TETRALIN | FUEL | ZEOLITE CATALYSTS | NAPHTHALENE | Sulfides | Catalysts | Zeolites | Analysis
Journal Article
Revista de Chimie, ISSN 0034-7752, 2017, Volume 67, Issue 9, pp. 1838 - 1842
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2008, Volume 201, Issue 2, pp. 203 - 218
Serotonin transporter (SERT) knockout (−/−) mice have an altered phenotype in adulthood, including high baseline anxiety and depressive-like behaviors,... 
Neurosciences | Temperature | SB 269970 | 8-hydroxy-2-(di- n -propylamino)tetralin (8-OH-DPAT) | High-performance liquid chromatography (HPLC) | Dopamine transporter (DAT) | N -[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- N -2-pyridinylcyclohexanecarboxamide maleate salt (WAY 100635) | Biomedicine | GBR 12909 | 5-hydroxy-L-tryptophan (5-HTP) | 5-carboxamidotryptamine maleate (5-CT) | Pharmacology/Toxicology | Serotonin syndrome behaviors | Psychiatry | 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) | KNOCK-OUT MICE | EARLY-LIFE BLOCKADE | PSYCHIATRY | N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide maleate salt (WAY 100635) | 5-HT7 RECEPTOR ANTAGONIST | DEFICIENT MICE | NEUROSCIENCES | 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN 8-OH-DPAT | TARGETED DISRUPTION | HYPOTHERMIC RESPONSE | PHARMACOLOGY & PHARMACY | POSTNATAL-DEVELOPMENT | RAT-BRAIN | REUPTAKE INHIBITOR | Brain Chemistry - drug effects | Brain - anatomy & histology | Clorgyline - pharmacology | Serotonin Plasma Membrane Transport Proteins - deficiency | Male | Piperazines - toxicity | 5-Hydroxytryptophan - pharmacology | Hypothermia - chemically induced | Serotonin - pharmacology | Serotonin Receptor Agonists - pharmacology | Brain - metabolism | Serotonin Plasma Membrane Transport Proteins - genetics | Tranylcypromine - pharmacology | Female | Drug Therapy, Combination | Phenols - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Dopamine Uptake Inhibitors - pharmacology | Hydroxyindoleacetic Acid - metabolism | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Hydroxyindoleacetic Acid - analysis | Sulfonamides - pharmacology | Piperazines - pharmacology | Mice, Knockout | Brain - drug effects | Drug Synergism | Serotonin Syndrome - chemically induced | Catecholamines - antagonists & inhibitors | Animals | Catecholamines - classification | Serotonin - metabolism | Serotonin - analogs & derivatives | Mice | Pyridines - pharmacology | Serotonin 5-HT1 Receptor Antagonists | Amino acids | Neurotransmitters | Animal behavior | Psychopharmacology | Rodents | Index Medicus
Journal Article
Brain, ISSN 0006-8950, 12/2008, Volume 131, Issue 12, pp. 3380 - 3394
Appearance of dyskinesia is a common problem of long-term l-DOPA treatment in Parkinson's disease patients and represents a major limitation for the... 
Serotonin agonists | Parkinson's disease | MPTP monkeys | L-DOPA | Dyskinesia | Serotonin 5-HT1 Receptor Agonists | Receptors, N-Methyl-D-Aspartate - metabolism | Macaca fascicularis | Motor Activity - drug effects | Dyskinesia, Drug-Induced - prevention & control | Parkinson Disease - drug therapy | Corpus Striatum - metabolism | Antiparkinson Agents - therapeutic use | Parkinsonian Disorders - drug therapy | Female | Parkinson Disease - metabolism | Drug Therapy, Combination | Disease Models, Animal | Pyridines - therapeutic use | Dyskinesia, Drug-Induced - etiology | Drug Evaluation, Preclinical - methods | Pyridines - administration & dosage | Drug Administration Schedule | Levodopa - therapeutic use | Proto-Oncogene Proteins c-fos - metabolism | 8-Hydroxy-2-(di-n-propylamino)tetralin - therapeutic use | Treatment Outcome | Parkinsonian Disorders - chemically induced | Antiparkinson Agents - adverse effects | Serotonin Receptor Agonists - therapeutic use | 8-Hydroxy-2-(di-n-propylamino)tetralin - administration & dosage | Animals | Levodopa - adverse effects | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Serotonin Receptor Agonists - administration & dosage | Index Medicus | Abridged Index Medicus | monkeys | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | MPTP | Klinisk medicin
Journal Article
Energy Conversion and Management, ISSN 0196-8904, 04/2018, Volume 161, pp. 234 - 242
[Display omitted] •Upgrading of VR was conducted in a hydrogen-donor solvent/activated carbon system.•The developed system achieved high performance at... 
Hydrogen-donor solvent | Upgrading | Activated carbon | Vacuum residue | Supercritical tetralin | PYROLYSIS BIO-OIL | SUPERCRITICAL M-XYLENE | ENERGY & FUELS | ASPHALTENES | MECHANICS | THERMODYNAMICS | HYDROCRACKING | TETRALIN | HEAVY FRACTIONS | THERMAL HYDROGENATION | COKE FORMATION | CATALYSTS | Usage | Oxidoreductases | Metal catalysts | Hydrogen | Dehydrogenation | Petroleum
Journal Article